REQUEST A DEMO
Total
USD $0.00
FAQ
Secure shopping

Healthcare and pharma

The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.

The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.

CEE Pharma and Healthcare Sector Report 2025-2026 - Page 1
CEE Pharma and Healthcare Sector Report 2025-2026 EMIS Insights Industry Reports

The CEE pharmaceutical and healthcare sector demonstrates remarkable resilience amid regional economic pressures, with each country adopting distinct strategies to address similar challenges. The overall market continues its growth trajectory, though ...

View more details
USD 995 Date: June 2025 Language: English
Format: PDF
Add to basket
CEE Pharma and Healthcare Sector Report 2024-2025 - Page 1
CEE Pharma and Healthcare Sector Report 2024-2025 EMIS Insights Industry Reports

Poland's healthcare and pharmaceutical industry is making significant strides, despite facing substantial challenges. The ongoing war in Ukraine, which followed the COVID-19 pandemic, has placed considerable pressure on the Polish healthcare system. ...

View more details
USD 995 Date: August 2024 Language: English
Format: PDF
Add to basket
USD 495 Date: August 2023 Language: English
Format: PDF
Add to basket
Romania Pharma and Healthcare Sector Report 2020/2021 - Page 1
Romania Pharma and Healthcare Sector Report 2020/2021 EMIS Insights Industry Reports

Healthcare expenditure in Romania has been increasing steadily in recent years (up by 15.6% y/y in 2017), but remains the lowest in the EU28, both in per capita purchasing power and as a share of GDP (5.2% in 2017). An Ageing population and ...

View more details
USD 495 Date: May 2020 Language: English
Format: PDF
Add to basket
Emerging Europe Pharma and Healthcare Sector Report 2019/2023 - Page 1
Emerging Europe Pharma and Healthcare Sector Report 2019/2023 EMIS Insights Industry Reports

Although quite different in terms of political and economic systems, the Emerging Europe countries share certain similarities when it comes to their demographic situation and health profile. With the exception of Turkey, whose average birth rate is ...

View more details
USD 495 Date: February 2020 Language: English
Format: PDF
Add to basket
Romania Pharma and Healthcare Sector Report 2018/2019 - Page 1
Romania Pharma and Healthcare Sector Report 2018/2019 EMIS Insights Industry Reports

Expenditure on healthcare in Romania reached RON 35.2bn in 2015, according to data provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was characterised by the lowest per capita ...

View more details
USD 495 Date: July 2018 Language: English
Format: PDF
Add to basket